If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSherborne Inv C Regulatory News (SIGC)

Share Price Information for Sherborne Inv C (SIGC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 52.50
Ask: 53.50
Change: 0.00 (0.00%)
Spread: 1.00 (1.905%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 53.00
SIGC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Investment in Barclays PLC

19 Mar 2018 07:36

RNS Number : 1010I
Sherborne Investors (Guernsey)C Ltd
19 March 2018
 

Sherborne Investors (Guernsey) C Limited

LEI 213800L8QL59OCFOCB40

19 March 2018

 

Sherborne Investors (Guernsey) C Limited

Statement re Investment in Barclays PLC

 

 

The board of Sherborne Investors (Guernsey) C Limited (the "Company") notes that Barclays PLC ("Barclays") has released to the market a TR-1 notification submitted to it by Sherborne Investors Management LP ("Sherborne Investors"). Sherborne Investors is the parent of Sherborne Investors Management (Guernsey) LLC, the investment manager of SIGC, LP, a limited partnership in which the Company is the principal investor (the "Partnership").

 

Funds managed by Sherborne Investors, including the Partnership, have acquired in the aggregate 5.2% of the voting rights of Barclays.

 

As provided in the limited partnership agreement of the Partnership, the board of the Company has approved Sherborne Investors' recommendation of the Barclays investment. Sherborne Investors has advised the Company that its turnaround assumptions indicate a potential return on the investment in line with Sherborne Investors' customary return objectives.

 

As at 16 March 2018, Sherborne Investors has invested £580 million of the Company's capital in Barclays shares and derivatives.

 

Based on various factors, including market conditions and Sherborne Investors' evaluation of the investment prospects for Barclays, Sherborne Investors has advised the Company that it reserves the right to increase or decrease its investment in Barclays without further notice to the Company.

 

The Company also announces that, due to a change in investment prospects, Sherborne Investors elected to liquidate the Partnership's investment of approximately £85 million in another company in October 2017. All of the proceeds of sale, including a realised profit of approximately 10% on invested capital, were returned to the Company, pending reinvestment, which has now occurred.

 

This announcement includes inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No.596/2014 ("MAR").

 

-Ends-

 

Enquiries: 

 

FTI Consulting +44 (0)20 3727 1000

Jonathon Brill

James Styles

 

Numis Securities Limited (Broker) +44 (0)20 7260 1000

David Benda

Nathan Brown

 

Sherborne Investors (Guernsey) C Limited +44 (0)14 8173 5827

Talmai Morgan (Chairman)

Nick Robilliard (Administrator)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRGGUPWWUPRUMB
Date   Source Headline
9th May 20247:00 amRNSNotice of AGM
1st May 20247:00 amRNSNet Asset Value(s)
30th Apr 20246:00 pmRNSAnnual Financial Report
30th Apr 20245:57 pmRNSDividend Declaration
30th Apr 20245:54 pmRNSFinal Results
2nd Apr 20247:00 amRNSNet Asset Value(s)
1st Mar 20247:00 amRNSNet Asset Value(s)
1st Feb 20247:00 amRNSNet Asset Value(s)
2nd Jan 20247:00 amRNSNet Asset Value(s)
1st Dec 20237:00 amRNSNet Asset Value(s)
1st Nov 20237:00 amRNSNet Asset Value(s)
25th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20237:00 amRNSNet Asset Value(s)
5th Sep 20237:00 amRNSDividend Declaration
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSNet Asset Value(s)
1st Aug 20237:00 amRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSNet Asset Value(s)
1st Jun 20237:00 amRNSNet Asset Value(s)
23rd May 20233:14 pmRNSResult of AGM
18th May 20237:00 amRNSInvestment Update
3rd May 20237:00 amRNSNotice of AGM
2nd May 20237:00 amRNSNet Asset Value(s)
20th Apr 20237:00 amRNSDividend Declaration
20th Apr 20237:00 amRNSAnnual Financial Report
20th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSNet Asset Value(s)
21st Mar 20237:00 amRNSHolding(s) in Company
1st Mar 20237:00 amRNSNet Asset Value(s)
1st Feb 20237:00 amRNSNet Asset Value(s)
16th Jan 20237:00 amRNSDirectorate Change
3rd Jan 20237:00 amRNSNet Asset Value(s)
1st Dec 20227:00 amRNSNet Asset Value(s)
1st Nov 20227:00 amRNSNet Asset Value(s)
31st Oct 20226:00 pmRNSHolding(s) in Company
28th Oct 20226:00 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSNet Asset Value(s)
1st Sep 20227:00 amRNSNet Asset Value(s)
18th Aug 20227:00 amRNSDividend Declaration
18th Aug 20227:00 amRNSHalf-year Report
1st Aug 20227:00 amRNSNet Asset Value(s)
1st Jul 20225:33 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSNet Asset Value(s)
8th Jun 20227:00 amRNSNavient Investment Update
1st Jun 20227:00 amRNSNet Asset Value(s)
26th May 20224:50 pmRNSResult of AGM
9th May 20227:00 amRNSNotice of AGM
3rd May 20227:00 amRNSNet Asset Value(s)
29th Apr 20227:00 amRNSFinal Results
29th Apr 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.